Business / Finance

RSS

Endo International revenues increase $719M to 1% in Q2 2014

Endo International plc today reported second quarter 2014 revenues of $719 million, an increase of 1 percent compared to second quarter 2013 revenues of $712 million.

31 Jul 2014

Genae establishes offices in London to provide high quality research services on global scale

genae, a global Contract Research Organization (CRO) and services provider for the medical industries, announced today the incorporation of genae UK in London.

31 Jul 2014

BD reports 5.1% increase in third fiscal quarter revenues

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014, representing an increase of 5.1 percent from the prior-year period, or 4.6 percent on a foreign currency-neutral basis.

From BD (Becton, Dickinson and Company) 31 Jul 2014

Nelipak completes acquisition of Flexpak

Nelipak Corporation announced today that it has closed on the acquisition of Debond Corporation.

30 Jul 2014

Glide Pharma licenses prostate cancer diagnostic technology from FScan

Glide Pharmaceutical Technologies Ltd today announced that it has taken an exclusive worldwide licence to an innovative prostate cancer diagnostic technology from FScan Ltd, a Durham University spin-out company.

30 Jul 2014

EDG Partners announces growth equity investment in MMIS

EDG Partners today announced a growth equity investment in MMIS, Inc., a global technology company that develops and markets compliance and collaboration software solutions for pharmaceutical and medical device companies.

29 Jul 2014

Sequenom's total revenues increase 62% to $39.8 million in Q2 2014

Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $39.8 million for the second quarter of 2014, an increase of 62% compared to revenues of $24.5 million for the second quarter of 2013.

From Quest Diagnostics 29 Jul 2014

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.

From Ortho-Clinical Diagnostics, Inc. 28 Jul 2014

Psychemedics' Q2 revenue increases 12% to $7.7 million

Psychemedics Corporation today announced second quarter financial results for the period ended June 30, 2014. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 7, 2014 to be paid on August 18, 2014.

28 Jul 2014

athenahealth expands strategic agreement with Henry Schein

athenahealth, Inc., a leading provider of cloud-based services for electronic health record (EHR), practice management, and care coordination, and Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health, and medical practitioners, today announced an expansion of their strategic agreement announced on May 21, 2014.

28 Jul 2014

Avidus acquires Truestar Health

Avidus Management Group Inc. is pleased to announce that further to its news release of July 16, 2014, it has completed the acquisition of substantially all of the assets of Truestar Health Inc., a Toronto based network-marketing company (the "Acquisition").

28 Jul 2014

Syneron Medical to host investor meeting to highlight opportunities in body contouring/fat treatment market

Syneron Medical Ltd., a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, at approximately 10:00 am to 1:00 pm ET in New York City. The meeting will highlight Syneron's opportunity in the fast growing body contouring and fat treatment market, with a focus on the UltraShape system, which received FDA clearance for fat cell destruction in April 2014.

26 Jul 2014

CanTx, Novogen name two key CMOs to manufacture clinical batches of anti-cancer drug Cantrixil

Oncology drug developer, CanTx Inc., and its parent company, Novogen Ltd., today announced that they have named two key contract manufacturing organizations (CMOs) to produce clinical batches of the experimental anti-cancer drug, Cantrixil.

26 Jul 2014

Semler Scientific revenues increase $371,000 to 78% in second quarter 2014

Semler Scientific, Inc., an emerging medical risk assessment company that develops patented products that assist healthcare providers in monitoring patients and evaluating chronic diseases, today reported financial results for the second quarter and six months ended June 30, 2014.

26 Jul 2014

Bitcoin Collect acquires medical device company, Good Vibration Shoes

Bitcoin Collect, Inc., today announced that it has discontinued its plans to develop virtual currency software, and has acquired a company with an exciting proprietary product in the medical devices industry.

26 Jul 2014

Todd Mitchem Consulting to conduct cannabis business workshops in early fall

Todd Mitchem Consulting, in conjunction with Cannabrand, the first full-service recreational cannabis marketing agency, will present "I Choose Cannabis and Business" workshops slated for five cities in September and October 2014.

26 Jul 2014

Solanbridge Group acquires majority interest in Buzznbrewz.com

Solanbridge Group Inc is pleased to announce that SLNX has acquired the majority interest in Buzznbrewz.com and the Letter of Intent issued on July 11, 2014 has been replaced with a fully executed Purchase Agreement.

25 Jul 2014

Galmed reports net loss of $3.9 million for six months ended June 30, 2014

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones, today announced financial results for the period ended June 30, 2014.

25 Jul 2014

IDEXX revenues increase 11% to $390M in second quarter 2014

IDEXX Laboratories, Inc. today reported that revenues for the second quarter of 2014 increased 11% versus the prior year period to $390 million.

25 Jul 2014

Malvern acquires MicroCal business and Affinity Biosensors' Archimedes product

Malvern Instruments Ltd (Malvern, UK) has today announced that it has completed the acquisition of MicroCal from GE Healthcare Life Sciences and has also purchased the Archimedes particle characterization system from Affinity Biosensors LLC (Santa Barbara, CA).

25 Jul 2014